Overview This page contains the latest trade data of Acyclic monoamines nes, derivatives and salts. In 2023, Acyclic monoamines nes, derivatives and salts were the world's 1897th most traded product, with a total trade of $1.21B. Between 2022 and 2023 the exports of Acyclic monoamines nes, derivatives and salts decreased by -20%, from $1.51B to $1.21B. Trade in Acyclic monoamines nes, derivatives and salts represent 0.0054% of total world trade.
Acyclic monoamines nes, derivatives and salts are a part of Amine Compounds.
Exports In 2023 the top exporters of Acyclic monoamines nes, derivatives and salts were China ($467M), Germany ($190M), Belgium ($152M), United States ($121M), and Philippines ($79.1M).
Imports In 2023 the top importers of Acyclic monoamines nes, derivatives and salts were United States ($148M), Japan ($123M), South Korea ($77.3M), Germany ($70.2M), and Austria ($62.3M).
Ranking Acyclic monoamines nes, derivatives and salts ranks 1426th in the Product Complexity Index (PCI).
Description Acyclic monoamines and derivatives are used in a variety of conditions including as antihypertensives, antidepressants, antipsychotics, and antiemetics. They are also used to treat Parkinson's disease.